CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | – | 448 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,918,722 | $6,006,000 | 4.90% |
| Tamarack Advisers, LP | 4,400,000 | $13,882,000 | 2.18% |
| AlphaOne Investment Services, LLC | 580,965 | $1,824,000 | 0.60% |
| CLOUGH CAPITAL PARTNERS L P | 3,061,064 | $9,581,000 | 0.50% |
| Rock Springs Capital Management LP | 1,200,000 | $3,751,000 | 0.24% |
| TURNER INVESTMENTS LLC | 150,000 | $470,000 | 0.16% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 5,397,007 | $16,893,000 | 0.14% |
| SABBY MANAGEMENT, LLC | 484,505 | $1,521,000 | 0.06% |
| PUTNAM INVESTMENTS LLC | 3,673,622 | $11,536,000 | 0.03% |
| ARDSLEY ADVISORY PARTNERS LP | 28,900 | $90,000 | 0.01% |